Clinical Trial Update: Adjunctive Intravenous Ascorbic Acid for Advanced Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This entry reports a Phase 2 trial evaluating adjunctive intravenous ascorbic acid for advanced non-small cell lung cancer, which is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Ascorbic acid (Vitamin C)

Snippet

Sponsor: The Canadian College of Naturopathic Medicine | Conditions: Lung Cancer | Phase 2 | Status: RECRUITING